LAM
MED icon

Lingohr Asset Management’s Medifast MED Stock Holding History

Lingohr Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,232
Closed -$352K – 67
2023
Q4 		$352K Hold
5,232
– – 0.8% 69
2023
Q3 		$392K Hold
5,232
– – 1.02% 61
2023
Q2 		$482K Hold
5,232
– – 1.23% 53
2023
Q1 		$542K Buy
5,232
+1,894
+57% +$210K 1.38% 34
2022
Q4 		$385K Buy
+3,338
New +$389K 1.08% 62

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lingohr Asset Management's MED Position: Q1 2024 in Review

Lingohr Asset Management sold out of Medifast (MED) in Q1 2024, closing a stake of 5,232 shares — an estimated $352K sold.

Lingohr Asset Management first reported a position in MED in Q4 2022 and held it in 5 quarters. The position peaked at $542K in Q1 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Lingohr Asset Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Lingohr Asset Management sold 5,232 Medifast shares in Q1 2024, an estimated $352K.
  • Lingohr Asset Management first reported a position in Medifast in Q4 2022 and held it in 5 quarters.
  • Lingohr Asset Management's Medifast position peaked at $542K in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Lingohr Asset Management's 13F filing for Q1 2024, filed 14 May 2024.